Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The language of chromatin modification in human cancers
Shuai Zhao, C. David Allis, Gang Greg Wang
Nature reviews. Cancer (2021) Vol. 21, Iss. 7, pp. 413-430
Open Access | Times Cited: 292

Showing 1-25 of 292 citing articles:

Signal pathways of melanoma and targeted therapy
Weinan Guo, Huina Wang, Chunying Li
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 224
Cancer epigenetics in clinical practice
Verónica Dávalos, Manel Esteller
CA A Cancer Journal for Clinicians (2022) Vol. 73, Iss. 4, pp. 376-424
Open Access | Times Cited: 145
Triple negative breast cancer (TNBC): Non-genetic tumor heterogeneity and immune microenvironment: Emerging treatment options
Jae Young So, Joyce E. Ohm, Stan Lipkowitz, et al.
Pharmacology & Therapeutics (2022) Vol. 237, pp. 108253-108253
Open Access | Times Cited: 126
Spatially resolved epigenomic profiling of single cells in complex tissues
Tian Lu, Cheen Euong Ang, Xiaowei Zhuang
Cell (2022) Vol. 185, Iss. 23, pp. 4448-4464.e17
Open Access | Times Cited: 115
Small molecule inhibitors targeting the cancers
Guihong Liu, Tao Chen, Xin Zhang, et al.
MedComm (2022) Vol. 3, Iss. 4
Open Access | Times Cited: 87
Histone lysine acetyltransferase inhibitors: an emerging class of drugs for cancer therapy
Jeffrey D. White, Frederick A. Derheimer, Kristen Jensen-Pergakes, et al.
Trends in Pharmacological Sciences (2024) Vol. 45, Iss. 3, pp. 243-254
Open Access | Times Cited: 19
tRNA-derived small RNAs in human cancers: roles, mechanisms, and clinical application
Manli Zhou, Xiaoyun He, Jing Zhang, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 19
Cancer plasticity in therapy resistance: Mechanisms and novel strategies
Xing Niu, Wenjing Liu, Zhang Yinling, et al.
Drug Resistance Updates (2024) Vol. 76, pp. 101114-101114
Closed Access | Times Cited: 15
Mature chromatin packing domains persist after RAD21 depletion in 3D
Wing Shun Li, Lucas Carter, Luay M. Almassalha, et al.
Science Advances (2025) Vol. 11, Iss. 4
Open Access | Times Cited: 2
The roles of histone modifications in tumorigenesis and associated inhibitors in cancer therapy
Yunkai Yang, Min Zhang, Yan Wang
Journal of the National Cancer Center (2022) Vol. 2, Iss. 4, pp. 277-290
Open Access | Times Cited: 58
Metabolic and Epigenetic Regulation by Estrogen in Adipocytes
Jan-Inge Bjune, Pouda Panahandeh Strømland, Regine Å. Jersin, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 53
How to Slow down the Ticking Clock: Age-Associated Epigenetic Alterations and Related Interventions to Extend Life Span
Anne-Marie Galow, Shahaf Peleg
Cells (2022) Vol. 11, Iss. 3, pp. 468-468
Open Access | Times Cited: 44
Discovery of a dual WDR5 and Ikaros PROTAC degrader as an anti-cancer therapeutic
Dongxu Li, Xufen Yu, Jithesh Kottur, et al.
Oncogene (2022) Vol. 41, Iss. 24, pp. 3328-3340
Open Access | Times Cited: 40
Construction of homo and heteronuclear Ru(II), Ir(III) and Re(I) complexes for target specific cancer therapy
Sudhindra Pete, Nilmadhab Roy, Binoy Kar, et al.
Coordination Chemistry Reviews (2022) Vol. 460, pp. 214462-214462
Closed Access | Times Cited: 39
Crosstalk between RNA m6A and DNA methylation regulates transposable element chromatin activation and cell fate in human pluripotent stem cells
Tongyu Sun, Yueyuan Xu, Yu Xiang, et al.
Nature Genetics (2023) Vol. 55, Iss. 8, pp. 1324-1335
Open Access | Times Cited: 38
Development and Recent Advances in Lysine and N-Terminal Bioconjugation for Peptides and Proteins
Ajcharapan Tantipanjaporn, Man‐Kin Wong
Molecules (2023) Vol. 28, Iss. 3, pp. 1083-1083
Open Access | Times Cited: 27
The chromatin network helps prevent cancer-associated mutagenesis at transcription-replication conflicts
Aleix Bayona‐Feliú, Emilia Herrera‐Moyano, Nibal Badra-Fajardo, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 27
Understanding Cancer’s Defense against Topoisomerase-Active Drugs: A Comprehensive Review
Nilesh Kumar Sharma, Anjali Bahot, Gopinath Sekar, et al.
Cancers (2024) Vol. 16, Iss. 4, pp. 680-680
Open Access | Times Cited: 15
Tubulin alpha-1b chain was identified as a prognosis and immune biomarker in pan-cancer combing with experimental validation in breast cancer
Yiyang Wang, Yongxiang Li, Yubo Jing, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 12
Targeting the mSWI/SNF complex in POU2F-POU2AF transcription factor-driven malignancies
Tongchen He, Lanbo Xiao, Yuanyuan Qiao, et al.
Cancer Cell (2024) Vol. 42, Iss. 8, pp. 1336-1351.e9
Open Access | Times Cited: 11
KMT2C and KMT2D aberrations in breast cancer
Emily Tinsley, Philip Bredin, Sinéad Toomey, et al.
Trends in cancer (2024) Vol. 10, Iss. 6, pp. 519-530
Closed Access | Times Cited: 10
Mechanotransduction and epigenetic modulations of chromatin: Role of mechanical signals in gene regulation
Jagdish Mishra, Subhajit Chakraborty, Niharika Niharika, et al.
Journal of Cellular Biochemistry (2024) Vol. 125, Iss. 3
Closed Access | Times Cited: 9
Small-molecule-based targeted therapy in liver cancer
Ming Yue, Yanqiu Gong, Xuewen Fu, et al.
Molecular Therapy (2024) Vol. 32, Iss. 10, pp. 3260-3287
Closed Access | Times Cited: 9
Simultaneous detection of 5-methylcytosine and 5-hydroxymethylcytosine at specific genomic loci by engineered deaminase-assisted sequencing
Neng-Bin Xie, Min Wang, Tong-Tong Ji, et al.
Chemical Science (2024) Vol. 15, Iss. 26, pp. 10073-10083
Open Access | Times Cited: 8
Prostate cancer epigenetics — from pathophysiology to clinical application
Vera Constâncio, João Lobo, José Pedro Sequeira, et al.
Nature Reviews Urology (2025)
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top